Javascript must be enabled to continue!
Gastrin/cholecystokinin type B receptors in the kidney: molecular, pharmacological, functional characterization, and localization
View through CrossRef
BackgroundGastrin/cholecystokinin type B receptors (CCKBRs) can be found on parietal cells and smooth muscle cells and are the predominant brain CCK receptors. Recent cloning studies indicate that this receptor type might also be expressed in the kidney.Materials and methodsWe used Northern blot analysis in guinea pig. kidney and reverse transcriptase polymerase chain reaction (RT‐PCR) in several murine kidney cell lines to evaluate this organ for the expression of the CCKBRs. The receptor was pharmacologically characterized by displacement experiments using [125I]‐BH‐CCKs and various agonists and antagonists. Polyclonal antibodies vs. the CCKBRs were raised in chicken, and immunohistochemistry on tissue sections was used to localize the receptor within the organ. The effect of gastrin on renal cell growth was measured using proximal tubulus (MCT) cells, which were cultured with gastrin (10−9 M) for 24–72 h. Cell counts and [3H]‐thymidine incorporation experiments were performed.ResultsCCKBR transcripts can be detected in kidney RNA (tubules > glomeruli > interstitium). RT‐PCR revealed CCKBR transcripts in proximal tubules (MCT cells) and in mesangium (MMC). The medullary thick ascending limb of Henle's loop and several control tissues such as liver and muscle were negative. Displacement experiments using [125I]‐BH‐CCK and various agonists and antagonists identified binding sites with typical CCKBR pharmacology. CCKBRs were localized in the proximal tubulus, distal collecting ducts and mesangium cells. Treatment of rested MCT cells with gastrin 17‐1 induced cell proliferation and [3H]‐thymidine incorporation by at least 40% compared with normal growth (P < 0.05).ConclusionThese results show for the first time that CCKBRs are present in selected areas of the kidney, and strongly confirm our previous observation that this organ expresses binding sites for [125I]‐gastrin. Furthermore, gastrin might act as a growth factor in the kidney.
Title: Gastrin/cholecystokinin type B receptors in the kidney: molecular, pharmacological, functional characterization, and localization
Description:
BackgroundGastrin/cholecystokinin type B receptors (CCKBRs) can be found on parietal cells and smooth muscle cells and are the predominant brain CCK receptors.
Recent cloning studies indicate that this receptor type might also be expressed in the kidney.
Materials and methodsWe used Northern blot analysis in guinea pig.
kidney and reverse transcriptase polymerase chain reaction (RT‐PCR) in several murine kidney cell lines to evaluate this organ for the expression of the CCKBRs.
The receptor was pharmacologically characterized by displacement experiments using [125I]‐BH‐CCKs and various agonists and antagonists.
Polyclonal antibodies vs.
the CCKBRs were raised in chicken, and immunohistochemistry on tissue sections was used to localize the receptor within the organ.
The effect of gastrin on renal cell growth was measured using proximal tubulus (MCT) cells, which were cultured with gastrin (10−9 M) for 24–72 h.
Cell counts and [3H]‐thymidine incorporation experiments were performed.
ResultsCCKBR transcripts can be detected in kidney RNA (tubules > glomeruli > interstitium).
RT‐PCR revealed CCKBR transcripts in proximal tubules (MCT cells) and in mesangium (MMC).
The medullary thick ascending limb of Henle's loop and several control tissues such as liver and muscle were negative.
Displacement experiments using [125I]‐BH‐CCK and various agonists and antagonists identified binding sites with typical CCKBR pharmacology.
CCKBRs were localized in the proximal tubulus, distal collecting ducts and mesangium cells.
Treatment of rested MCT cells with gastrin 17‐1 induced cell proliferation and [3H]‐thymidine incorporation by at least 40% compared with normal growth (P < 0.
05).
ConclusionThese results show for the first time that CCKBRs are present in selected areas of the kidney, and strongly confirm our previous observation that this organ expresses binding sites for [125I]‐gastrin.
Furthermore, gastrin might act as a growth factor in the kidney.
Related Results
Glycine-extended gastrin enhances somatostatin release from cultured rabbit fundic D-cells
Glycine-extended gastrin enhances somatostatin release from cultured rabbit fundic D-cells
The role of the peptide hormone gastrin in stimulating gastric acid secretion is well established. Mature amidated gastrin is processed from larger peptide precursor forms. Increas...
Menin-MLL Inhibitor MI-503 Blocks Menin Nuclear Export and Suppresses Hypergastrinemia
Menin-MLL Inhibitor MI-503 Blocks Menin Nuclear Export and Suppresses Hypergastrinemia
AbstractMenin is the protein product of the Multiple Endocrine Neoplasia 1 (MEN1) gene locus at 11q13 and is a known tumor suppressor of neuroendocrine neoplasms (NENs). Gastrin-ex...
Gastrin Enhances Autophagy and Promotes Gastric Carcinoma Proliferation via Inducing AMPKα
Gastrin Enhances Autophagy and Promotes Gastric Carcinoma Proliferation via Inducing AMPKα
Gastric cancer (GC) is one of the most frequent epithelial malignancies worldwide. The gastrointestinal (GI) peptide gastrin is an important regulator of the secretion and release ...
Indoor Localization System Based on RSSI-APIT Algorithm
Indoor Localization System Based on RSSI-APIT Algorithm
An indoor localization system based on the RSSI-APIT algorithm is designed in this study. Integrated RSSI (received signal strength indication) and non-ranging APIT (approximate pe...
The Dopamine Receptors
The Dopamine Receptors
Abstract
Dopamine receptors have a prominent place in our understanding of brain function. Drugs blocking dopamine receptors are used as antipsy...
Renal Ewing Sarcoma: A Case Report and Literature Review
Renal Ewing Sarcoma: A Case Report and Literature Review
Abstract
Introduction
Primary renal Ewing sarcoma is an extremely rare and aggressive tumor, representing less than 1% of all renal tumors. This case report contributes valuable in...
Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase.
Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase.
AIMS: To determine the association, if any, between H pylori genotype and the gastric mucosal variations in the levels of gastrin, somatostatin, tryptase, and histamine. METHODS: 4...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...

